This paper reports a case of chorioamnionitis due to Morganella morganii in a mother who presented with ruptured membranes at 24 weeks' gestation and was treated with dexamethasone and prophylactic ampicillin. Her premature infant developed severe early onset infection due to the same organism and expired.
Morganella morganii, a Gram-negative facultative anaerobe that is a normal constituent of the gastrointestinal flora, is an uncommon cause of human infection. This organism is characteristically resistant to ampicillin and sensitive to aminoglycosides and third-generation cephalosporins. The risk of M. morganii infection is increased among patients with prolonged urinary catheterization 1 or with impaired defenses due to underlying disease such as diabetes, 2 malignancy, 3 splenectomy, 4 or AIDS. 5 M. morganii may also be a cause of nosocomial infection and may cause epidemics among hospitalized patients. 6 -8 Although it has been suggested that infection with M. morganii might be relatively indolent, 9 a number of reports attest to the fact that this organism can cause serious or fatal illness. 1, 8 M. morganii appears to be a rare cause of infection in the pregnant woman or neonate. 10 -12 We recently cared for an extremely premature infant with fatal early onset infection who was born to a mother with M. morganii chorioamnionitis.
CASE REPORT
A 31-year-old human immunodeficiency virus-negative woman presented at 24 weeks' gestation with ruptured membranes. She had undergone placement of a cervical cerclage at 15 weeks of pregnancy because of a history of two previous second trimester fetal losses. The cerclage remained in place until delivery. At the time of admission, the patient's temperature was 98.2°F; her white blood cell count was 9230. It was decided to attempt to prolong her pregnancy, and she was started on dexamethasone to enhance pulmonary maturation as well as prophylactic ampicillin. She received a total of two doses of dexamethasone and three doses of ampicillin before delivery. The following day, after the membranes had been ruptured for ϳ21 hours, she developed fever with a temperature of 100.8°F. After 1 hour, her temperature increased to 102.3°F and she developed shaking chills and abdominal pain. A diagnosis of chorioamnionitis was made, and a cesarean section was performed ϳ1 hour later. She was started on ampicillin, metronidazole, and gentamicin postoperatively and responded well to antibiotic therapy. She became afebrile on the third postoperative day, was placed on oral ampicillin and metronidazole on the fourth postoperative day, and was discharged on the following day.
The infant was a 675-gm girl with Apgar scores of 2 and 5 at 1 and 5 minutes, respectively. She was intubated in the delivery room, received surfactant, and was transported to the neonatal intensive care unit and placed on a ventilator. Ampicillin (100 mg/kg per day) and gentamicin (5 mg/kg per dose every 48 hours) were begun. The in-
fant was hypotensive and required several boluses of isotonic fluid as well as an infusion of dopamine and dobutamine to maintain her blood pressure. She was also anemic and required multiple blood transfusions. She developed leukopenia and thrombocytopenia as well as a severe metabolic acidosis that did not respond to bicarbonate. Her respiratory status deteriorated and it became impossible to oxygenate her despite the administration of an additional dose of surfactant and a trial of high-frequency oscillatory ventilation. Terminally, she developed bleeding from the endotracheal tube and expired at 48 hours of age. Culture reports became available only after the infant's death. The cultures of maternal blood and urine were negative; however, the infant's blood culture as well as the culture of the maternal surface of the placental surface grew M. morganii, which was resistant to ampicillin and sensitive to cefotaxime and gentamicin. Postmortem cultures were done of the infant's blood, pleural fluid, and peritoneal fluid; all were positive for M. morganii, with the same sensitivity pattern as the original organism.
DISCUSSION
Although the mother was a previously healthy nondiabetic, several factors were present that may have increased her risk of developing chorioamnionitis due to this unusual organism. The presence of a cervical cerclage increases the risk of chorioamnionitis. 13, 14 Antenatal steroids are of demonstrated benefit in accelerating fetal lung maturity as well as the maturity of other organ systems and have an established role in the management of women with preterm rupture of membranes. 15 However, there are concerns that their use may increase the risk of infection, 16 and it is possible that their use in this case contributed to the development of M. morganii chorioamnionitis. Although this infant was clearly at increased risk of early onset infection because of extreme prematurity and the presence of chorioamnionitis, neonatal infection with M. morganii can occur without obvious risk factors. A term infant with late onset infection due to this organism has been reported whose only risk factor was having undergone an uncomplicated circumcision. That infant had no evidence of infection at the circumcision site at the time of readmission with sepsis. 12 The use of parenteral ampicillin in cases of preterm rupture of membranes has been shown to reduce the risk of group B streptococcal infection in the infant as well as reduce the risk of infectious complications in the mother. However, there are concerns that routine intrapartum antibiotic prophylaxis with ampicillin may lead to the emergence of infections due to resistant Gram-negative organisms. An increased incidence of early onset neonatal infection with ampicillinresistant Escherichia coli in infants born to mothers who received ampicillin prophylaxis during pregnancy has been reported. 17 An apparent increase in the incidence of ampicillin-resistant Gramnegative infections following the adoption of intrapartum ampicillin prophylaxis has also been observed in our nursery. During the month of this infant's birth, two other infants with early onset infection due to ampicillin-resistant organisms, one a Salmonella and the other an E. coli, were admitted to our neonatal unit. The mother of the infant with Salmonella had ruptured membranes for Ͼ24 hours and received two doses of ampicillin. The infant with E. coli was born at 32 weeks' gestation to a mother with prolonged rupture of membranes who received ampicillin for 3 days and dexamethasone for 2 days.
Our experience serves to emphasize that intrapartum antibiotic prophylaxis with ampicillin, although effective in reducing the risk of early onset group B streptococcal infection, will not provide complete protection against early onset infection due to Gram-negative bacteria and may actually increase the risk of infection with resistant organisms. However, the routine use of broader spectrum prophylactic coverage in mothers with premature rupture of membranes cannot currently be justified because of concerns regarding drug toxicity, cost, and the emergence of resistant bacteria and yeast.
M. morganii is a significant pathogen that is capable of causing severe neonatal infection. Our patient had evidence of active, disseminated infection at the time of death, despite treatment with gentamicin, an antibiotic to which the organism was sensitive in vitro. This finding gives added support to the recommendation that neonates with M. morganii not be treated with an aminoglycoside alone; a third-generation cephalosporin, such as cefotaxime, should be used as well to enhance bacterial killing and reduce the possibility of the emergence of resistant organisms. 12 It is important for clinicians to be aware that infection with ampicillin-resistant Gram-negative organisms is more likely in infants born to mothers who have received prophylactic ampicillin antenatally. Because aminoglycoside monotherapy may not be adequate in neonatal Gram-negative sepsis, a third generation cephalosporin such as cefotaxime should be added to the antibiotic regimen in infants who are at increased risk of infection with ampicillin-resistant Gram-negative organisms.
